| Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy S Bose, P Saha, B Chatterjee, AK Srivastava Seminars in Cancer Biology 86, 568-579, 2022 | 31 | 2022 |
| MicroRNAs: as critical regulators of tumor-associated macrophages B Chatterjee, P Saha, S Bose, D Shukla, N Chatterjee, S Kumar, ... International journal of molecular sciences 21 (19), 7117, 2020 | 23 | 2020 |
| MicroRNAs: Key modulators of inflammation-associated diseases B Chatterjee, M Sarkar, S Bose, MT Alam, AA Chaudhary, AK Dixit, ... Seminars in Cell & Developmental Biology 154, 364-373, 2024 | 16 | 2024 |
| Complexity of tumor microenvironment: therapeutic role of Curcumin and its metabolites S Prasad, P Saha, B Chatterjee, AA Chaudhary, R Lall, AK Srivastava Nutrition and Cancer 75 (1), 1-13, 2022 | 8 | 2022 |
| MiRNA-3163 limits ovarian cancer stem-like cells via targeting SOX-2 transcription factor B Chatterjee, S Bose, R Singh, AK Dixit, L Puia, AK Srivastava Non-coding RNA Research, 2024 | 2 | 2024 |
| Expression Profile, Molecular Association, and Clinical Significance of POLD4 in Glioblastoma MT Alam, MS Ali, H Goel, J Singh, B Chatterjee, S Bose, V Hadda, ... Cellular and Molecular Neurobiology 43 (7), 3753-3765, 2023 | 1 | 2023 |
| Inhibition of DNA polymerase eta-mediated translesion DNA synthesis by small molecule sensitizes ovarian cancer stem-like cells to chemotherapy A Srivastava, S Bose, P Saha, MT Alam, B Chatterjee, M Sarkar, A Dixit, ... | 1 | 2023 |
| Dengue virus NS1 leads to downregulation of HNF4 alpha in liver cells resulting in a decrease in coagulation factors I, V, X, and XIII, contributing to coagulopathy S Das, MH Mallik, P Chattopadyay, S Mallick, D Karmakar, S Ghora, ... Journal of Virology, e01418-24, 2024 | | 2024 |
| Preferential deployment of DNA repair pathways: The Tumor associated macrophages acting as a coordinator in response to cisplatin treatment in ovarian cancer B Chatterjee, A Srivastava 7th European Congress of Immunology 54 (1), 1587, 2024 | | 2024 |
